Latest CVE Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Zacks Equity Research | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Nilanjan Banerjee | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Zacks Equity Research | Zacks Equity Research | Initiates Coverage | Buy | - | |
| Chris MacCulloch | Desjardins | Initiates | Buy | $33.07 | |
| Lloyd Byrne | Jefferies | Maintains | Buy | $34.47 | |
| Neil Mehta | Goldman Sachs | Maintains | Buy | $36.00 | |
| Lloyd Byrne | Jefferies | Maintains | Buy | $30.14 → $35.17 +5.03 (16.7%) | |
| Kevin Fisk | Scotiabank | Maintains | Buy | $31.58 → $33.73 +2.15 (6.8%) | |
| Gregory Pardy | RBC Capital | Maintains | Buy | $32.30 → $33.73 +1.43 (4.4%) | |
| Patrick O'rourke | ATB Cormark Capital | Reiterates | Buy | $30.50 | |
| Menno Hulshof | TD Cowen | Maintains | Buy | $32.30 | |
| Michael Barth, CFA | Raymond James | Maintains | Buy | $29.42 → $30.14 +0.72 (2.5%) | |
| Patrick O'rourke | ATB Cormark Capital | Reiterates | Buy | $42.50 | |
| Menno Hulshof | TD Cowen | Maintains | Buy | $45.00 | |
| Michael Barth, CFA | Raymond James | Maintains | Buy | $41.00 → $42.00 +1.00 (2.4%) |
